Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer

(2014) P Zhang et al.   Cell Death & Disease

Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells

(2013) Ziyuan Wang et al.   ANTI-CANCER DRUGS

Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice

(2013) Yunfei Wang et al.   BIOMATERIALS

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy

(2013) Sara De Dosso et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Metabolic changes during ovarian cancer progression as targets for sphingosine treatment

(2013) Angela S. Anderson et al.   EXPERIMENTAL CELL RESEARCH

The Arf/p53 Protein Module, Which Induces Apoptosis, Down-regulates Histone H2AX to Allow Normal Cells to Survive in the Presence of Anti-cancer Drugs

(2013) Yuko Atsumi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inflammasome-Activated Caspase 7 Cleaves PARP1 to Enhance the Expression of a Subset of NF-κB Target Genes

(2012) Süheda Erener et al.   MOLECULAR CELL

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

(2012) Bradley N Bidwell et al.   NATURE MEDICINE

Emerging roles of the tumor-associated stroma in promoting tumor metastasis

(2012) Yoshiya Horimoto et al.   Cell Adhesion & Migration

The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy

(2011) Laurence M. Wood et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Structural basis of RNA recognition and activation by innate immune receptor RIG-I

(2011) Fuguo Jiang et al.   NATURE

Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance

(2011) W Li et al.   ONCOGENE

Resistance to MEK Inhibitors: Should We Co-Target Upstream?

(2011) P. I. Poulikakos et al.   Science Signaling

Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells

(2009) Jen-Chung Ko et al.   BIOCHEMICAL PHARMACOLOGY

The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells

(2009) Yehong Sun et al.   CANCER INVESTIGATION

γH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids

(2009) Qvarnström   INTERNATIONAL JOURNAL OF ONCOLOGY

Polymorphisms in the Caspase7 gene and the risk of lung cancer

(2008) Won Kee Lee et al.   LUNG CANCER

ISG15 as a novel tumor biomarker for drug sensitivity

(2008) Shyamal D. Desai et al.   MOLECULAR CANCER THERAPEUTICS